Shares of China vaccine makers slump on U.S. waiver support
Shares in Chinese vaccine makers slumped on Thursday after U.S. President Joe Biden’s support for a proposed waiver of intellectual property rights on COVID-19 vaccines sent investors scrambling to reconsider high valuations.
Read More
Canada’s ex-finance minister breached ethics rules in charity dealings 
Judge axes employee wage claims, keeps others in Wawa data breach case